ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma

Cell Death and Differentiation

Volumn 17, Issue 11, 2010, Pages 1751-1759

  Harada, C ^a   Namekata, K ^a   Guo, X ^a   Yoshida, H ^b   Mitamura, Y ^c   Matsumoto, Y ^a   Tanaka, K ^d   Ichijo, H ^e   Harada, T ^a,b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

ASK1; Glaucoma; glia; glutamate transporter; neural cell death

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; EXCITATORY AMINO ACID TRANSPORTER; GLUTATHIONE; MALONALDEHYDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; ENZYME DEFICIENCY; FEMALE; GLAUCOMA; GLIA CELL; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; KNOCKOUT MOUSE; MALE; MAMMAL; MOUSE; MOUSE STRAIN; NERVE CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; NORMAL TENSION GLAUCOMA; OPTIC NERVE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RETINA GANGLION CELL; STRAIN DIFFERENCE; VISION;

ANIMALS; APOPTOSIS; CELL DEATH; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTATHIONE; LOW TENSION GLAUCOMA; MAP KINASE KINASE KINASE 5; MICE; MICE, MUTANT STRAINS; NERVE DEGENERATION; NEUROGLIA; NITRIC OXIDE SYNTHASE; OPTIC NERVE; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RETINA; RETINAL GANGLION CELLS; RETINAL NEURONS; TUMOR NECROSIS FACTOR-ALPHA; VISION, OCULAR;

MAMMALIA; MUS;

EID: 77957850977     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.62     Document Type: Article

References (45)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-393.
2. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol 2007; 125: 30-37.
3. Seki M, Lipton SA. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog Brain Res 2008; 173: 495-510.
4. Lindsey JD, Weinreb RN. Elevated intraocular pressure and transgenic applications in the mouse. J Glaucoma 2005; 14: 318-320.
5. John SW, Smith RS, Savinova OV, Hawes N, Chang B, Turnbull D et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 1998; 39: 951-962.
6. Chiu K, Chang R, So KF. Laser-induced chronic ocular hypertension model on SD rats. J Vis Exp 2007; 10: 549.
7. Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004; 111: 1641-1648.
8. Zhang X, Cheng M, Chintala SK. Optic nerve ligation leads to astrocyte-associated matrix metalloproteinase-9 induction in the mouse retina. Neurosci Lett 2004; 356: 140-144.
9. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997; 276: 1699-1702.
10. Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, Inoue Y et al. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Eur J Neurosci 1998; 10: 976-988.
11. Matsugami TR, Tanemura K, Mieda M, Nakatomi R, Yamada K, Kondo T et al. Indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proc Natl Acad Sci USA 2006; 103: 12161-12166.
12. Harada T, Harada C, Watanabe M, Inoue Y, Sakagawa T, Nakayama N et al. Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc Natl Acad Sci USA 1998; 95: 4663-4666.
13. Harada T, Harada C, Nakamura K, Quah HA, Okumura A, Namekata K et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007; 117: 1763-1770.
14. Naskar R, Vorwerk CK, Dreyer EB. Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Invest Ophthalmol Vis Sci 2000; 41: 1940-1944.
15. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2005; 46: 877-883.
16. Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev 2008; 22: 1451-1464.
17. Hattori K, Naguro I, Runchel C, Ichijo H. The roles of ASK family proteins in stress responses and diseases. Cell Commun Signal 2009; 24: 7-9.
18. Harada C, Nakamura K, Namekata K, Okumura A, Mitamura Y, Iizuka Y et al. Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo. Am J Pathol 2006; 168: 261-269.
19. Aihara M, Lindsey JD, Weinreb RN. Twenty-four-hour pattern of mouse intraocular pressure. Exp Eye Res 2003; 77: 681-686.
20. Namekata K, Harada C, Guo X, Kikushima K, Kimura A, Fuse N et al. Interleukin-1 attenuates normal tension glaucoma-like retinal degeneration in EAAC1 deficient mice. Neurosci Lett 2009; 465: 160-164.
21. Hangai M, Yoshimura N, Hiroi K, Mandai M, Honda Y. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp Eye Res 1996; 63: 501-509.
22. Goureau O, Régnier-Ricard F, Courtois Y. Requirement for nitric oxide in retinal neuronal cell death induced by activated Müller glial cells. J Neurochem 1999; 72: 2506-2515.
23. Da Silva J, Pierrat B, Mary JL, Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 1997; 272: 28373-28380.
24. Zoia CP, Tagliabue E, Isella V, Begni B, Fumagalli L, Brighina L et al. Fibroblast glutamate transport in aging and in AD: correlations with disease severity. Neurobiol Aging 2005; 26: 825-832.
25. Tamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006; 246: 79-83.
26. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K et al. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005; 12: 19-24.
27. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 2007; 104: 13444-13449.
28. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci 2003; 8: 1140-1156.
29. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, Iijima H et al. Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci 2008; 49: 4453-4457.
30. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005; 6: 587-592.
31. +-ATPase via actin depolymerization. Mol Cell Biol 2008; 28: 3273-3280.
32. Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000; 23: 618-625.
33. Koeberle PD, Bähr M. The upregulation of GLAST-1 is an indirect antiapoptotic mechanism of GDNF and neurturin in the adult CNS. Cell Death Differ 2008; 15: 471-483.
34. Jomary C, Thomas M, Grist J, Milbrandt J, Neal MJ, Jones SE. Expression patterns of neurturin and its receptor components in developing and degenerative mouse retina. Invest Ophthalmol Vis Sci 1999; 40: 568-574.
35. Harada C, Harada T, Quah HM, Maekawa F, Yoshida K, Ohno S et al. Potential role of glial cell line-derived neurotrophic factor receptors in Müller glial cells during light-induced retinal degeneration. Neuroscience 2003; 122: 229-235.
36. Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, Ohno S et al. Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 2002; 22: 9228-9236.
37. Harada T, Harada C, Nakayama N, Okuyama S, Yoshida K, Kohsaka S et al. Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 2000; 26: 533-541.
38. Lambiase A, Aloe L, Centofanti M, Parisi V, Mantelli F, Colafrancesco V et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc Natl Acad Sci USA 2009; 106: 13469-13474.
39. Osborne NN. Pathogenesis of ganglion 'cell death' in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Prog Brain Res 2008; 173: 339-352.
40. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006; 26: 12633-12641.
41. Toda N, Nakanishi-Toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 2007; 26: 205-238.
42. Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, Wiedemann P et al. Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 2009; 28: 423-451.
43. Harada C, Mitamura Y, Harada T. The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells. Prog Retin Eye Res 2006; 25: 149-164.
44. Guo X, Harada C, Namekata K, Kikushima K, Mitamura Y, Yoshida H et al. Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis. Neurosci Lett 2009; 462: 281-285.
45. Haddadin RI, Oh DJ, Kang MH, Filippopoulos T, Gupta M, Hart L et al. SPARC-null mice exhibit lower intraocular pressures. Invest Ophthalmol Vis Sci 2009; 50: 3771-3777.